Teleradiology Boom: A new market outlook projects teleradiology to surge from $8.8B (2022) to $46.7B by 2032, driven by faster imaging tech and remote specialist coverage. Drug Pricing Pressure: Romania’s national health insurer says medicine pricing rules are delaying access to innovation by 2–3 years and calls for a pricing and reimbursement overhaul. Big Pharma Leadership Shift: Sanofi names ex-Roche exec Paulo Fontoura as global R&D chief, as the company navigates pipeline setbacks and ramps R&D spending. Medicaid Work Rules Backfire: A federal Medicaid rule update is criticized for being unusually tough on frail patients while offering more generous exemptions for caregivers—raising uninsured risks. US Pharma Deal: Aurobindo Pharma USA wins FTC approval to buy Lannett for $250M, aiming to expand complex generics and add manufacturing capacity for up to 4B doses annually. Digital Records Push (India): Karnataka plans OTP-consented, ABDM-aligned digital patient records to cut repeat paperwork across public hospitals. Nurses Vote to Unionize: Chicago’s Saint Mary of Nazareth Hospital nurses back unionization amid workload concerns after Prime Healthcare’s acquisition. AI in Biomanufacturing: Singapore’s ChemT raises $4M to apply AI to biologics manufacturing, targeting more predictable scale-up and yields. Wellness Caution (Turkey): An investigation highlights misleading “NAD” IV therapy claims marketed by private clinics using celebrity promotions. Research & Discovery: Studies spotlight new Alzheimer’s approaches (reprogramming immune defenses) and AI-assisted drug discovery/manufacturing efforts.